194 related articles for article (PubMed ID: 33136180)
21. Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis.
Hein DW
Mutat Res; 2002 Sep; 506-507():65-77. PubMed ID: 12351146
[TBL] [Abstract][Full Text] [Related]
22. Role of the human N-acetyltransferase 2 genetic polymorphism in metabolism and genotoxicity of 4, 4'-methylenedianiline.
Salazar-González RA; Zhang X; Doll MA; Lykoudi A; Hein DW
Arch Toxicol; 2019 Aug; 93(8):2237-2246. PubMed ID: 31292670
[TBL] [Abstract][Full Text] [Related]
23. Isoform-selective inactivation of human arylamine N-acetyltransferases by reactive metabolites of carcinogenic arylamines.
Liu L; Wagner CR; Hanna PE
Chem Res Toxicol; 2009 Dec; 22(12):1962-74. PubMed ID: 19842618
[TBL] [Abstract][Full Text] [Related]
24. Alkylaniline-hemoglobin adducts and risk of non-smoking-related bladder cancer.
Gan J; Skipper PL; Gago-Dominguez M; Arakawa K; Ross RK; Yu MC; Tannenbaum SR
J Natl Cancer Inst; 2004 Oct; 96(19):1425-31. PubMed ID: 15467031
[TBL] [Abstract][Full Text] [Related]
25. Tissue distribution of N-acetyltransferase 1 and 2 catalyzing the N-acetylation of 4-aminobiphenyl and O-acetylation of N-hydroxy-4-aminobiphenyl in the congenic rapid and slow acetylator Syrian hamster.
Hein DW; Doll MA; Nerland DE; Fretland AJ
Mol Carcinog; 2006 Apr; 45(4):230-8. PubMed ID: 16482518
[TBL] [Abstract][Full Text] [Related]
26. 4,4'-methylenedianiline-induced hepatotoxicity is modified by N-acetyltransferase 2 (NAT2) acetylator polymorphism in the rat.
Zhang X; Lambert JC; Doll MA; Walraven JM; Arteel GE; Hein DW
J Pharmacol Exp Ther; 2006 Jan; 316(1):289-94. PubMed ID: 16192314
[TBL] [Abstract][Full Text] [Related]
27. Human
Hein DW; Doll MA; Habil MR
Front Pharmacol; 2022; 13():821133. PubMed ID: 35281898
[TBL] [Abstract][Full Text] [Related]
28. Analysis of the involvement of human N-acetyltransferase 1 in the genotoxic activation of bladder carcinogenic arylamines using a SOS/umu assay system.
Oda Y
Mutat Res; 2004 Oct; 554(1-2):399-406. PubMed ID: 15450435
[TBL] [Abstract][Full Text] [Related]
29. The role of N-acetylation polymorphisms in smoking-associated bladder cancer: evidence of a gene-gene-exposure three-way interaction.
Taylor JA; Umbach DM; Stephens E; Castranio T; Paulson D; Robertson C; Mohler JL; Bell DA
Cancer Res; 1998 Aug; 58(16):3603-10. PubMed ID: 9721868
[TBL] [Abstract][Full Text] [Related]
30. Genetic heterogeneity among slow acetylator N-acetyltransferase 2 phenotypes in cryopreserved human hepatocytes.
Doll MA; Hein DW
Arch Toxicol; 2017 Jul; 91(7):2655-2661. PubMed ID: 28516247
[TBL] [Abstract][Full Text] [Related]
31. The effect of the rs1799931 G857A (G286E) polymorphism on N-acetyltransferase 2-mediated carcinogen metabolism and genotoxicity differs with heterocyclic amine exposure.
Hein DW; Salazar-González RA; Doll MA; Zang Y
Arch Toxicol; 2023 Oct; 97(10):2697-2705. PubMed ID: 37592049
[TBL] [Abstract][Full Text] [Related]
32. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
Okkels H; Sigsgaard T; Wolf H; Autrup H
Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
[TBL] [Abstract][Full Text] [Related]
33. Metabolic activation of N-hydroxyarylamines and N-hydroxyarylamides by 16 recombinant human NAT2 allozymes: effects of 7 specific NAT2 nucleic acid substitutions.
Hein DW; Doll MA; Rustan TD; Ferguson RJ
Cancer Res; 1995 Aug; 55(16):3531-6. PubMed ID: 7627960
[TBL] [Abstract][Full Text] [Related]
34. Differences between human slow N-acetyltransferase 2 alleles in levels of 4-aminobiphenyl-induced DNA adducts and mutations.
Bendaly J; Doll MA; Millner LM; Metry KJ; Smith NB; Pierce WM; Hein DW
Mutat Res; 2009 Dec; 671(1-2):13-9. PubMed ID: 19682468
[TBL] [Abstract][Full Text] [Related]
35. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms.
Hein DW; Doll MA; Fretland AJ; Leff MA; Webb SJ; Xiao GH; Devanaboyina US; Nangju NA; Feng Y
Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):29-42. PubMed ID: 10667461
[TBL] [Abstract][Full Text] [Related]
36. Acetyl coenzyme A kinetic studies on
Habil MR; Doll MA; Hein DW
Front Pharmacol; 2022; 13():931323. PubMed ID: 36386142
[TBL] [Abstract][Full Text] [Related]
37. Codominant expression of N-acetylation and O-acetylation activities catalyzed by N-acetyltransferase 2 in human hepatocytes.
Doll MA; Zang Y; Moeller T; Hein DW
J Pharmacol Exp Ther; 2010 Aug; 334(2):540-4. PubMed ID: 20430842
[TBL] [Abstract][Full Text] [Related]
38. Variation in enzymes of arylamine procarcinogen biotransformation among bladder cancer patients and control subjects.
Vaziri SA; Hughes NC; Sampson H; Darlington G; Jewett MA; Grant DM
Pharmacogenetics; 2001 Feb; 11(1):7-20. PubMed ID: 11207033
[TBL] [Abstract][Full Text] [Related]
39. Acetyltransferases and susceptibility to chemicals.
Hein DW; Rustan TD; Doll MA; Bucher KD; Ferguson RJ; Feng Y; Furman EJ; Gray K
Toxicol Lett; 1992 Dec; 64-65 Spec No():123-30. PubMed ID: 1471166
[TBL] [Abstract][Full Text] [Related]
40. Cloning, expression, and functional characterization of rapid and slow acetylator polymorphic N-acetyl-transferase encoding genes of the Syrian hamster.
Ferguson RJ; Doll MA; Rustan TD; Hein DW
Pharmacogenetics; 1996 Feb; 6(1):55-66. PubMed ID: 8845861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
